Profile data is unavailable for this security.
About the company
Katakura Industries Co.,Ltd. is a Japan-based company mainly engaged in the real estate operation and leasing, as well as the manufacture and sale of mechanical maintenance products and auto parts. The Company operates through four business segments. The Textile segment is engaged in the manufacture and sale of underwear, socks, silk products, casual innerwear, adjusted underwear and functional fibers, as well as the brand licensing business. The Pharmaceutical segment manufactures and sells ethical drugs. The Machinery-Related segment manufactures and sells fire trucks, automobile parts, agricultural machinery and imports and sells petroleum products. The Real Estate segment operates shopping centers and rents real estate. The Company is also involved in the home improvement, building management services, sales of flower visiting insects, low potassium lettuce, production and sales of Hanabiratake and day services.
- Revenue in JPY (TTM)40.98bn
- Net income in JPY5.84bn
- Incorporated1920
- Employees941.00
- LocationKatakura Industries Co LtdNichirei Akashicho Bldg.6-4, Akashi-choCHUO-KU 104-8312JapanJPN
- Phone+81 368321873
- Fax+81 368320256
- Websitehttps://www.katakura.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fuji Pharma Co Ltd | 54.57bn | 2.33bn | 56.60bn | 1.76k | 23.82 | 1.16 | 9.00 | 1.04 | 95.46 | 95.46 | 2,233.29 | 1,959.48 | 0.5765 | 1.49 | 2.83 | 31,007,950.00 | 2.46 | 4.51 | 3.93 | 6.76 | 40.82 | 40.57 | 4.27 | 8.51 | 0.876 | 17.58 | 0.3885 | 25.98 | 12.01 | 8.87 | -51.19 | 7.55 | 8.07 | 7.94 |
| Oncolys Biopharma Inc | 28.55m | -2.06bn | 70.07bn | 35.00 | -- | 17.51 | -- | 2,454.48 | -80.66 | -80.66 | 1.11 | 136.64 | 0.0074 | 0.00 | 0.1004 | -- | -53.08 | -53.26 | -58.54 | -60.19 | 0.00 | -- | -7,209.58 | -484.93 | 9.54 | -424.60 | 0.0741 | -- | -9.04 | -38.10 | -22.16 | -- | 2.22 | -- |
| ASKA Pharmaceutical Holdings Co Ltd | 68.70bn | 4.91bn | 72.63bn | 1.63k | 14.60 | 1.04 | 9.37 | 1.06 | 172.92 | 172.92 | 2,421.07 | 2,420.68 | 0.6729 | 1.37 | 3.62 | 42,094,980.00 | 4.93 | 5.50 | 6.64 | 7.07 | 48.33 | 47.56 | 7.32 | 7.98 | 1.23 | 75.35 | 0.1551 | 16.60 | 2.06 | 4.07 | -32.39 | 51.04 | 9.49 | 31.48 |
| Nxera Pharma Co Ltd | 29.62bn | -12.53bn | 84.52bn | 374.00 | -- | 1.39 | -- | 2.85 | -138.60 | -138.60 | 328.05 | 674.04 | 0.2069 | 0.8144 | 4.11 | -- | -8.75 | -3.79 | -9.90 | -4.16 | 72.32 | 80.12 | -42.31 | -22.17 | 1.90 | -1.30 | 0.4847 | -- | 2.71 | 27.35 | -158.99 | -- | 42.87 | -- |
| JCR Pharmaceuticals Co Ltd | 37.55bn | -2.44bn | 85.98bn | 987.00 | -- | 1.75 | 184.91 | 2.29 | -19.98 | -19.98 | 307.86 | 379.76 | 0.3432 | 0.4534 | 2.50 | 38,039,510.00 | -2.21 | 5.86 | -3.77 | 9.33 | 70.45 | 73.83 | -6.45 | 13.60 | 0.668 | -- | 0.5295 | 45.13 | -22.86 | 5.94 | -186.42 | -- | 15.37 | 20.11 |
| Cuorips Inc | 355.69m | -764.60m | 90.51bn | 56.00 | -- | 18.03 | -- | 254.45 | -93.30 | -93.30 | 43.60 | 607.39 | 0.0656 | 3.33 | 238.00 | 6,351,607.00 | -14.20 | -- | -14.62 | -- | 76.69 | -- | -216.57 | -- | 36.81 | -- | 0.00 | -- | 658.40 | -- | -1.92 | -- | -- | -- |
| Kyorin Pharmaceutical Co Ltd | 133.26bn | 10.77bn | 99.93bn | 2.00k | 8.90 | 0.6896 | 6.49 | 0.7499 | 187.40 | 187.40 | 2,319.59 | 2,417.37 | 0.6927 | 1.08 | 2.93 | 66,695,200.00 | 5.60 | 3.34 | 7.03 | 4.16 | 45.32 | 45.89 | 8.08 | 5.11 | 2.05 | -- | 0.1746 | 57.34 | 8.83 | 3.41 | 70.73 | 8.12 | 14.36 | -7.06 |
| Katakura Industries Co Ltd | 40.98bn | 5.84bn | 110.93bn | 941.00 | 17.28 | 1.10 | 12.61 | 2.71 | 182.30 | 182.30 | 1,278.51 | 2,853.06 | 0.2926 | 2.15 | 6.42 | 43,545,160.00 | 4.27 | 2.60 | 5.20 | 3.57 | 36.16 | 37.98 | 14.59 | 9.44 | 2.63 | -- | 0.0807 | 23.42 | -1.37 | -2.19 | 15.73 | 15.27 | -7.22 | 33.03 |
| Zeria Pharmaceutical Co Ltd | 86.61bn | 7.26bn | 111.08bn | 1.75k | 13.19 | 0.9976 | 7.63 | 1.28 | 164.79 | 164.79 | 1,964.97 | 2,178.21 | 0.5366 | 1.27 | 3.21 | 49,607,640.00 | 4.49 | 4.67 | 6.99 | 7.47 | 72.76 | 72.17 | 8.37 | 9.02 | 0.9739 | 11.41 | 0.2984 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
| Mochida Pharmaceutical Co Ltd | 111.92bn | 6.42bn | 135.19bn | 1.51k | 20.51 | 0.9583 | 14.40 | 1.21 | 181.16 | 181.16 | 3,156.95 | 3,876.77 | 0.6427 | 1.67 | 3.02 | 74,214,190.00 | 3.69 | 4.50 | 4.47 | 5.44 | 48.43 | 52.49 | 5.74 | 6.87 | 2.85 | -- | 0.0678 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
Data as of Feb 18 2026. Currency figures normalised to Katakura Industries Co Ltd's reporting currency: Japanese Yen JPY
14.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zennor Asset Management LLPas of 12 Feb 2026 | 1.59m | 4.51% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 704.34k | 2.00% |
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 647.90k | 1.84% |
| Morant Wright Management Ltd.as of 31 Dec 2025 | 450.00k | 1.28% |
| Dimensional Fund Advisors LPas of 31 Jan 2026 | 419.76k | 1.19% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 398.50k | 1.13% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 291.70k | 0.83% |
| Gutmann KAGas of 29 Aug 2025 | 175.50k | 0.50% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 143.00k | 0.41% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 2026 | 135.20k | 0.38% |
More ▼
Data from 31 Oct 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
